Steroidhormone receptors as targets for the therapy of breast and prostate cancer—recent advances, mechanisms of resistance, and new approaches
- 28 February 2005
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 93 (2-5) , 191-200
- https://doi.org/10.1016/j.jsbmb.2004.12.002
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Characterization of New Estrogen Receptor Destabilizing Compounds: Effects on Estrogen-Sensitive and Tamoxifen-Resistant Breast CancerJNCI Journal of the National Cancer Institute, 2004
- Progesterone involvement in breast development and tumorigenesis—as revealed by progesterone receptor “knockout” and “knockin” mouse modelsSteroids, 2003
- Molecular Determinants for the Tissue Specificity of SERMsScience, 2002
- Definition of the Molecular and Cellular Mechanisms Underlying the Tissue-selective Agonist/Antagonist Activities of Selective Estrogen Receptor ModulatorsRecent Progress in Hormone Research, 2002
- Estrogen receptor and breast cancerSeminars in Cancer Biology, 2001
- Molecular and pharmacological aspects of antiestrogen resistanceThe Journal of Steroid Biochemistry and Molecular Biology, 2001
- From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth centuryEuropean Journal Of Cancer, 1999
- Selective oestrogen receptor modulationEuropean Journal Of Cancer, 1999
- Antiestrogens: Mechanisms of action and resistance in breast cancerBreast Cancer Research and Treatment, 1997
- Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancerBritish Journal of Cancer, 1996